ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Illinois » Psychiatry

Top Psychiatry Prescribers in Illinois

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
DONNA DOBROWOLSKY MD

Psychiatry

1,075

$144K

45
23 are 65+

33%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

35%
prescriptions for brand name drugs

Avg: 24%

$134
Average prescription price

Avg: $125

J RODOS DO

Psychiatry

1,052

$164K

51
17 are 65+

24%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

37%
prescriptions for brand name drugs

Avg: 24%

$156
Average prescription price

Avg: $125

SETH TILZER M.D.

Psychiatry

901

$58.4K

153
67 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 24%

$65
Average prescription price

Avg: $125

REGINALD GIVENS MD

Psychiatry

381

$22.6K

102
11 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

12%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

18%
prescriptions for brand name drugs

Avg: 24%

$59
Average prescription price

Avg: $125

SHELDON GREENBERG M.D.

Psychiatry

875

$179K

59
16 are 65+

31%
patients receiving schedule two controlled substances

Avg: 3%

22%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

33%
prescriptions for brand name drugs

Avg: 24%

$205
Average prescription price

Avg: $125

SHEIKH LATIF M.D.

Psychiatry

1,319

$70.3K

146
106 are 65+

9%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 24%

$53
Average prescription price

Avg: $125

JOSEPH FANELLI MD

Psychiatry

1,705

$369K

126
31 are 65+

21%
patients receiving schedule two controlled substances

Avg: 3%

12%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

31%
prescriptions for brand name drugs

Avg: 24%

$216
Average prescription price

Avg: $125

JOSEPH BECK M.D.

Psychiatry

2,654

$377K

205
56 are 65+

13%
patients receiving schedule two controlled substances

Avg: 3%

17%
patients receiving schedule three controlled substances

Avg: 1%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

29%
prescriptions for brand name drugs

Avg: 24%

$142
Average prescription price

Avg: $125

RAYMOND GOUTTAMA MD

Psychiatry

1,858

$251K

174
40 are 65+

24%
patients receiving schedule two controlled substances

Avg: 3%

22%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

30%
prescriptions for brand name drugs

Avg: 24%

$135
Average prescription price

Avg: $125

AL DOYLE MD

Psychiatry

2,955

$421K

171
34 are 65+

18%
patients receiving schedule two controlled substances

Avg: 3%

11%
patients receiving schedule three controlled substances

Avg: 1%

8%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

31%
prescriptions for brand name drugs

Avg: 24%

$142
Average prescription price

Avg: $125

RALPH MENEZES M.D.

Psychiatry

3,353

$479K

289
21 are 65+

12%
patients receiving schedule two controlled substances

Avg: 3%

8%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 24%

$143
Average prescription price

Avg: $125

JOHN LAUER MD

Psychiatry

901

$66.1K

137
15 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

8%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 24%

$73
Average prescription price

Avg: $125

HISHAM SADEK MD

Psychiatry

4,011

$663K

297
34 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

33%
patients receiving schedule three controlled substances

Avg: 1%

11%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

36%
prescriptions for brand name drugs

Avg: 24%

$165
Average prescription price

Avg: $125

RAMESH VEMURI M.D.

Psychiatry

2,936

$438K

218
54 are 65+

18%
patients receiving schedule two controlled substances

Avg: 3%

17%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 24%

$149
Average prescription price

Avg: $125

DEEPAK KAPOOR M.D.

Psychiatry

4,496

$627K

309
61 are 65+

11%
patients receiving schedule two controlled substances

Avg: 3%

6%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 24%

$139
Average prescription price

Avg: $125

STEPHANIE VAN ULFT M. D.

Psychiatry

779

$93.7K

159
29 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 24%

$120
Average prescription price

Avg: $125

EDWIN GUMAPAS MD

Psychiatry

3,318

$399K

226
99 are 65+

18%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

29%
prescriptions for brand name drugs

Avg: 24%

$120
Average prescription price

Avg: $125

INNA GOLBER MD

Psychiatry

1,948

$75.5K

170
135 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 24%

$39
Average prescription price

Avg: $125

FEITENG SU MD

Psychiatry

2,866

$500K

198
21 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

30%
prescriptions for brand name drugs

Avg: 24%

$174
Average prescription price

Avg: $125

NAEEM QURESHI MD

Psychiatry

6,343

$855K

505
122 are 65+

7%
patients receiving schedule two controlled substances

Avg: 3%

4%
patients receiving schedule three controlled substances

Avg: 1%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

29%
prescriptions for brand name drugs

Avg: 24%

$135
Average prescription price

Avg: $125

CHANDRAGUPTA VEDAK MD

Psychiatry

3,549

$452K

181
74 are 65+

22%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 24%

$127
Average prescription price

Avg: $125

CRYSTAL SMITH M.D.

Psychiatry

1,973

$257K

224
34 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 24%

$130
Average prescription price

Avg: $125

ELIZABETH MIRKIN M.D.

Psychiatry

4,415

$539K

281
127 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 24%

$122
Average prescription price

Avg: $125

MANJIT SANDHU MD

Psychiatry

4,461

$636K

322
176 are 65+

12%
patients receiving schedule two controlled substances

Avg: 3%

3%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 24%

$143
Average prescription price

Avg: $125

SYED ANWAR MD

Psychiatry

7,910

$859K

544
128 are 65+

6%
patients receiving schedule two controlled substances

Avg: 3%

3%
patients receiving schedule three controlled substances

Avg: 1%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 24%

$109
Average prescription price

Avg: $125

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank